Cargando…
FOXQ1, a Novel Target of the Wnt Pathway and a New Marker for Activation of Wnt Signaling in Solid Tumors
BACKGROUND: The forkhead box transcription factor FOXQ1 has been shown to be upregulated in colorectal cancer (CRC) and metastatic breast cancer and involved in tumor development, epithelial-mesenchymal transition and chemoresistance. Yet, its transcriptional regulation is still unknown. METHODS: FO...
Autores principales: | Christensen, Jon, Bentz, Susanne, Sengstag, Thierry, Shastri, V. Prasad, Anderle, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608605/ https://www.ncbi.nlm.nih.gov/pubmed/23555880 http://dx.doi.org/10.1371/journal.pone.0060051 |
Ejemplares similares
-
FOXQ1 promotes the osteogenic differentiation of bone mesenchymal stem cells via Wnt/β-catenin signaling by binding with ANXA2
por: Xiang, Lusai, et al.
Publicado: (2020) -
Defining new criteria for selection of cell-based intestinal models using publicly available databases
por: Christensen, Jon, et al.
Publicado: (2012) -
Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis
por: Cui, Xiaohai, et al.
Publicado: (2017) -
Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors
por: Fu, Wen-bin, et al.
Publicado: (2018) -
The role of Wnt signaling pathway in tumor metabolic reprogramming
por: Mo, Yongzhen, et al.
Publicado: (2019)